Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
A novel lentivirus for quantitative assessment of gene knockdown in stem cell differentiation.
Alimperti S, Lei P, Tian J, Andreadis ST.
Gene Ther. 2012 Jan 12. doi: 10.1038/gt.2011.208. [Epub ahead of print]
Related citations
Cross-presentation of tumour antigens by human induced pluripotent stem cell-derived CD141(+)XCR1(+) dendritic cells.
Silk KM, Silk JD, Ichiryu N, Davies TJ, Nolan KF, Leishman AJ, Carpenter L, Watt SM, Cerundolo V, Fairchild PJ.
Gene Ther. 2011 Nov 10. doi: 10.1038/gt.2011.177. [Epub ahead of print]
Hypoxia-specific GM-CSF-overexpressing neural stem cells improve graft survival and functional recovery in spinal cord injury.
Kim HJ, Oh JS, An SS, Pennant WA, Gwak SJ, Kim AN, Han PK, Yoon DH, Kim KN, Ha Y.
Gene Ther. 2012 May;19(5):513-21. doi: 10.1038/gt.2011.137. Epub 2011 Oct 20.
Mitochondrial gene replacement in human pluripotent stem cell-derived neural progenitors.
Iyer S, Xiao E, Alsayegh K, Eroshenko N, Riggs MJ, Bennett JP Jr, Rao RR.
Gene Ther. 2012 May;19(5):469-75. doi: 10.1038/gt.2011.134. Epub 2011 Sep 15.
CDK4 and cyclin D1 allow human myogenic cells to recapture growth property without compromising differentiation potential.
Shiomi K, Kiyono T, Okamura K, Uezumi M, Goto Y, Yasumoto S, Shimizu S, Hashimoto N.
Gene Ther. 2011 Sep;18(9):857-66. doi: 10.1038/gt.2011.44. Epub 2011 Apr 14.
Elastin-like polypeptide matrices for enhancing adeno-associated virus-mediated gene delivery to human neural stem cells.
Kim JS, Chu HS, Park KI, Won JI, Jang JH.
Gene Ther. 2012 Mar;19(3):329-37. doi: 10.1038/gt.2011.84. Epub 2011 Jun 9.
Targeted suicide gene therapy for glioma using human embryonic stem cell-derived neural stem cells genetically modified by baculoviral vectors.
Zhao Y, Lam DH, Yang J, Lin J, Tham CK, Ng WH, Wang S.
Gene Ther. 2012 Feb;19(2):189-200. doi: 10.1038/gt.2011.82. Epub 2011 Jun 2.
Non-hematopoietic stem cells as factories for in vivo therapeutic protein production.
Sanz L, Compte M, Guijarro-Muñoz I, Álvarez-Vallina L.
Gene Ther. 2012 Jan;19(1):1-7. doi: 10.1038/gt.2011.68. Epub 2011 May 12. Review.
Optimal conditions for lentiviral transduction of engrafting human CD34+ cells.
Uchida N, Hsieh MM, Hayakawa J, Madison C, Washington KN, Tisdale JF.
Gene Ther. 2011 Nov;18(11):1078-86. doi: 10.1038/gt.2011.63. Epub 2011 May 5.
Highly efficient multipotent differentiation of human periodontal ligament fibroblasts induced by combined BMP4 and hTERT gene transfer.
Mi HW, Lee MC, Fu E, Chow LP, Lin CP.
Gene Ther. 2011 May;18(5):452-61. Epub 2011 Jan 13.
Quantification of lentiviral vector copy numbers in individual hematopoietic colony-forming cells shows vector dose-dependent effects on the frequency and level of transduction.
Charrier S, Ferrand M, Zerbato M, Précigout G, Viornery A, Bucher-Laurent S, Benkhelifa-Ziyyat S, Merten OW, Perea J, Galy A.
Gene Ther. 2011 May;18(5):479-87. Epub 2010 Dec 16.
Generation of dendritic cells and macrophages from human induced pluripotent stem cells aiming at cell therapy.
Senju S, Haruta M, Matsumura K, Matsunaga Y, Fukushima S, Ikeda T, Takamatsu K, Irie A, Nishimura Y.
Gene Ther. 2011 Sep;18(9):874-83. doi: 10.1038/gt.2011.22. Epub 2011 Mar 24.
A bidirectional promoter architecture enhances lentiviral transgenesis in embryonic and extraembryonic stem cells.
Golding MC, Mann MR.
Gene Ther. 2011 Aug;18(8):817-26. doi: 10.1038/gt.2011.26. Epub 2011 Mar 10.
MMP-2 mediates mesenchymal stem cell tropism towards medulloblastoma tumors.
Bhoopathi P, Chetty C, Gogineni VR, Gujrati M, Dinh DH, Rao JS, Lakka SS.
Gene Ther. 2011 Jul;18(7):692-701. doi: 10.1038/gt.2011.14. Epub 2011 Mar 3.
Indolactam V/GLP-1-mediated differentiation of human iPS cells into glucose-responsive insulin-secreting progeny.
Thatava T, Nelson TJ, Edukulla R, Sakuma T, Ohmine S, Tonne JM, Yamada S, Kudva Y, Terzic A, Ikeda Y.
Gene Ther. 2011 Mar;18(3):283-93. Epub 2010 Nov 4.
10-year stability of clinical-grade serum-free γ-retroviral vector-containing medium.
Herbst F, Ball CR, Zavidij O, Fessler S, Schmidt M, Veelken H, von Kalle C, Glimm H.
Gene Ther. 2011 Feb;18(2):210-2. Epub 2010 Nov 11.
The effects of mesenchymal stem cells injected via different routes on modified IL-12-mediated antitumor activity.
Seo SH, Kim KS, Park SH, Suh YS, Kim SJ, Jeun SS, Sung YC.
Gene Ther. 2011 May;18(5):488-95. Epub 2011 Jan 13.
Preclinical correction of human Fanconi anemia complementation group A bone marrow cells using a safety-modified lentiviral vector.
Becker PS, Taylor JA, Trobridge GD, Zhao X, Beard BC, Chien S, Adair J, Kohn DB, Wagner JE, Shimamura A, Kiem HP.
Gene Ther. 2010 Oct;17(10):1244-52. Epub 2010 May 20.
Signed outside: a surface marker system for transgenic cytoplasmic proteins.
Wohlgensinger V, Seger R, Ryan MD, Reichenbach J, Siler U.
Gene Ther. 2010 Oct;17(10):1193-9. Epub 2010 May 6.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on